Obesity, Akkermansia muciniphila, and Proton Pump Inhibitors: Is there a Link?
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 14 (6) , 524-530
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council
This publication has 22 references indexed in Scilit:
- Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2014
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesityProceedings of the National Academy of Sciences, 2013
- Cohort Profile: Geelong Osteoporosis StudyInternational Journal of Epidemiology, 2011
- Dealing With Dietary Measurement Error in Nutritional Cohort StudiesJNCI: Journal of the National Cancer Institute, 2011
- The role of fat mass index in determining obesityAmerican Journal of Human Biology, 2010
- Long-term treatment with proton pump inhibitor is associated with undesired weight gainWorld Journal of Gastroenterology, 2009
- The Mucin Degrader Akkermansia muciniphila Is an Abundant Resident of the Human Intestinal TractApplied and Environmental Microbiology, 2008
- Gastric Juice: A Barrier Against Infectious DiseasesBasic & Clinical Pharmacology & Toxicology, 2005
- Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacteriumInternational Journal of Systematic and Evolutionary Microbiology, 2004
- Fat-free mass index and fat mass index percentiles in Caucasians aged 18–98 yInternational Journal of Obesity, 2002